MYOS RENS Technology (MYOS) Stock Price, News & Analysis

Company Overview

MedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company is headquartered in Mississauga, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: $1.01 to $11.40
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 1.68 million shs
• Market Capitalization: $16.70 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MYOS Stock Analysis - Frequently Asked Questions

How were MYOS RENS Technology's earnings last quarter?

MYOS RENS Technology Inc. (NASDAQ:MYOS) released its earnings results on Tuesday, August, 6th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by $0.01. The business had revenue of $0.15 million for the quarter, compared to the consensus estimate of $0.14 million. MYOS RENS Technology had a negative net margin of 277.82% and a negative trailing twelve-month return on equity of 166.68%.

What other stocks do shareholders of MYOS RENS Technology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MYOS RENS Technology investors own include Chesapeake Energy (CHKAQ), Catalyst Pharmaceuticals (CPRX), Ampio Pharmaceuticals (AMPE), Biocept (BIOC), T2 Biosystems (TTOO), AbbVie (ABBV) and Global Blood Therapeutics (GBT).

Company Calendar

• Last Earnings: 8/06/2019
• Today: 5/25/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:MYOS
• CIK: 1402479
• Web: www.myosrens.com
• Phone: (905) 812-0023
• Fax: N/A
• Employees: 15
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-4,260,000.00
• Net Margins: -277.82%
• Pretax Margin: N/A
• Return on Equity: -166.68%
• Return on Assets: -104.95%

Debt

• Debt-to-Equity Ratio: 0.11
• Current Ratio: 3.78
• Quick Ratio: 1.94

Sales & Book Value

• Annual Sales: $1.03 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.13 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 12,192,000
• Free Float: N/A
• Market Cap: $16.70 million
• Optionable: Not Optionable
• Beta: 1.08